New surveillance data from the Vaccine Safety Datalink confirm a small but statistically significant increased risk for Guillain-Barré syndrome (GBS) in the 3 weeks after receipt of the Janssen/Johnson & Johnson COVID-19 vaccine. The Janssen vaccine (Ad26.COV2.S) is a replication-incompetent adenoviral vector vaccine. The data show no increased risk of […]
Read More
Johnson & Johnson stopped making its COVID-19 vaccine at a key facility in the Netherlands. The Johnson & Johnson shot is seen as a critical vaccine for poorer countries. But late last year the company paused production at the only plant making usable batches of the vaccine, people familiar with […]
Read More
Según Medscape Infectious Diseases, el responsable de la South Africa´s Medical Research Council ha comunicado que la doble dosis de la vacuna Ad26.CoV2-S de Janssen (J&J) tiene una efectividad del 85% para las hospitalizaciones causadas por la variante ómicron y que se mantiene al menos durante dos meses. El estudio incluyó 477.234 […]
Read More
A nationwide study of more than 3,600 adults found the Moderna vaccine does a better job at preventing COVID-19 hospitalizations than the two other vaccines being used in the United States, the Centers for Disease Control and Protection said Friday. “Among U.S. adults without immunocompromising conditions, vaccine effectiveness against COVID-19 […]
Read More
Johnson & Johnson’s Covid-19 vaccine may trigger a rare neurological condition in a small number of people who receive the vaccine, the Food and Drug Administration said Monday. Reports to a database operated jointly by the agency and the Centers for Disease Prevention and Control suggest there may be a […]
Read More
The Food and Drug Administration ended its recommended pause on the Johnson & Johnson Covid-19 vaccine on Friday and will add a warning to its label to note the potential risk of rare blood clots. The decision, which clears the way for states to resume vaccinations, came after a panel […]
Read More
Although there is no way to know how the vote will go when the CDC’s Advisory Committee on Immunization Practices meets later today on the recommended pause in use of the Johnson & Johnson vaccine, many experts predict the panel to suggest the J&J vaccine rollout start back up.. Few […]
Read More
Here are some of the latest developments on the COVID-19 vaccines: Safety of vaccine in pregnancy: Early results indicate that COVID-19 vaccination appears to be safe in the third trimester of pregnancy, according to a CDC study in the New England Journal of Medicine. Researchers compiled data from the v-safe pregnancy registry and […]
Read More
This edition of Medicine Matters addresses new safety concerns for Janssen’s viral vector vaccine: what to look for, what to do, what not to do, and what to tell your patients. Here’s the timeline: On February 27, 2021, the FDA authorized the emergency use of Janssen viral vector COVID-19 vaccine for those […]
Read More
On April 13, the CDC and the FDA issued a joint statement recommending a pause in Johnson & Johnson vaccine administration, pending review of six reported US cases of a rare and severe type of blood clot occurring after receiving the Johnson & Johnson vaccine. To date, more than 6.8 million doses of […]
Read More